epilepsy

2 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Xenon Pharma Raises $650M in Upsized Offering to Fund Pipeline Growth

Xenon Pharmaceuticals prices $650M upsized offering at $57/share with 10.5M shares. Proceeds fund pipeline acceleration; closes March 2026.
XENEpublic offeringcapital raise
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Supernus to Present at Three Major Healthcare Conferences in March

Supernus Pharmaceuticals will present at three major healthcare conferences in March 2026, updating investors on strategic initiatives and operational progress.
SUPNinvestor conferencebiopharmaceutical